As of Thursday close, Geron Corporation’s (NASDAQ:GERN) stock was down -$0.15, moving down -5.56 percent to $2.55. The average number of shares traded per day over the past five days has been 4,447,820 shares. 1 time new highs have been achieved over the past 5 days, with a -$0.46 fall in that time frame. In the last twenty days, the average volume was 3,709,070, while in the previous 50 days, it was 5,029,956.
Since last month, GERN stock retreated -21.30%. Shares of the company fell to $2.54 on 08/17/23, the lowest level in the past month. A 52-week high of $3.84 was reached on 01/04/23 after having rallying from a 52-week low of $1.95. Since the beginning of this year, GERN’s stock price has risen by 5.37% or $0.13, and marked a new high 2 times. However, the stock has declined by -33.59% since its 52-week high.
GERN stock investors should be aware that Geron Corporation (GERN) stock had its last reported insider trading activity 99 days ago on May 11. LAWLIS V BRYAN, the Director of the company, disposed of 35,000 shares for $3.00 on May 11. It resulted in a $105,000 divestment by the insider. Molineaux Susan sold 35,000 shares at an average price of $2.48 on May 01. The insider now owns 0 shares following the transaction. On Feb 10, Chairman, President and CEO SCARLETT JOHN A sold 446,668 shares at $3.00 apiece. The transaction was valued at $1,340,004.
Valuation Metrics
The stock’s beta is 0.83. Besides these, the trailing price-to-sales (P/S) ratio of 2660.26, the price-to-book (PB) ratio of 4.64.
Financial Health
In the three months ended June 29, Geron Corporation’s quick ratio stood at 5.20, while its current ratio was 5.20, showing that the company is able to pay off its debt. According to company report, the long-term debt-to-equity ratio for the quarter ending June 29 was 0.14, and the total debt-to-equity ratio was 0.17. Based on annual data, GERN earned $139.15 million in gross profit and brought in $0.6 million in revenue.
A company’s management is another factor that investors consider when determining the profitability of an investment. In the past year, return on investment (ROI) was -105.70%. Return on equity (ROE) for the past 12 months was -84.20%.
In Geron Corporation’s quarter-end financial report for June 29, it reported total debt of $40.8 million against cash and short-term investments of $314.48 million. According to the earnings report, the company had a higher net income in the recent quarter than it did in the previous quarter. GERN’s revenue fell -133.33% during the quarter, while net income inched up to $30000.0. While analysts expected Geron Corporation to report -$0.08 quarterly earnings, the actual figure was -$0.09 per share, beating the consensus estimate by -12.50%. During the quarter, the company generated -$54.67 million in EBITDA. The liabilities of Geron Corporation were 116.87 million at the end of its most recent quarter ended June 29, and its total debt was $55.93 million. The value of shareholders’ equity is $523.37 million.
Technical Picture
This quick technical analysis looks at Geron Corporation’s (GERN) price momentum. With a historical volatility rate of 59.43%, the RSI 9-day stood at 22.36% on 17 August.
With respect to its five-day moving average, the current Geron Corporation price is down by -15.28% percent or -$0.46. At present, GERN shares trade -18.01% below its 20-day simple moving average and +9.44% percent above its 100-day simple moving average. However, the stock is currently trading approximately -29.17% below its SMA50 and +5.81% above its SMA200.
Stochastic coefficient K was 13.63% and Stochastic coefficient D was 21.91%, while ATR was 0.15. Given the Stochastic reading of 1.41% for the 14-day period, the RSI (14) reading has been calculated as 28.24%. As of today, the MACD Oscillator reading stands at -0.15, while the 14-day reading stands at -0.25.
Analyst Ratings
Goldman launched its rating on Geron Corporation (NASDAQ: GERN) to a Neutral in a note to investors on March 28, 2023. Geron Corporation (GERN) has been rated Overweight by analysts. According to 0 brokerage firms, GERN is a sell, and 1 firms recommend it is a Hold. There are 0 analysts who say the stock is underweight. A total of 1 analyst rate Geron Corporation stock as buy, with 4 recommending it as overweight.
With a median target price of $5.00, the current consensus forecast for the stock is $4.00 – $6.00. Based on these forecasts, analysts predict Geron Corporation (GERN) will achieve an average price target of $4.83.
